These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 17584007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cysteinyl leukotriene blockade does not prevent acute mountain sickness.
    Muza SR, Kaminsky D, Fulco CS, Banderet LE, Cymerman A.
    Aviat Space Environ Med; 2004 May; 75(5):413-9. PubMed ID: 15152893
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute mountain sickness is not repeatable across two 12-hour normobaric hypoxia exposures.
    MacInnis MJ, Koch S, MacLeod KE, Carter EA, Jain R, Koehle MS, Rupert JL.
    Wilderness Environ Med; 2014 Jun; 25(2):143-51. PubMed ID: 24631230
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents.
    Harel Z, Riggs S, Vaz R, Flanagan P, Harel D.
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):183-6. PubMed ID: 15125904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m.
    Schommer K, Wiesegart N, Menold E, Haas U, Lahr K, Buhl H, Bärtsch P, Dehnert C.
    High Alt Med Biol; 2010 Jun; 11(1):19-25. PubMed ID: 20367484
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exhaled nitric oxide is associated with acute mountain sickness susceptibility during exposure to normobaric hypoxia.
    Macinnis MJ, Carter EA, Koehle MS, Rupert JL.
    Respir Physiol Neurobiol; 2012 Jan 15; 180(1):40-4. PubMed ID: 22027218
    [Abstract] [Full Text] [Related]

  • 14. Short-term intermittent hypoxia reduces the severity of acute mountain sickness.
    Wille M, Gatterer H, Mairer K, Philippe M, Schwarzenbacher H, Faulhaber M, Burtscher M.
    Scand J Med Sci Sports; 2012 Oct 15; 22(5):e79-85. PubMed ID: 22853822
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute mountain sickness: increased severity during simulated altitude compared with normobaric hypoxia.
    Roach RC, Loeppky JA, Icenogle MV.
    J Appl Physiol (1985); 1996 Nov 15; 81(5):1908-10. PubMed ID: 8941508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
    Nettis E, Colanardi MC, Paradiso MT, Ferrannini A.
    Clin Exp Allergy; 2004 Sep 15; 34(9):1401-7. PubMed ID: 15347373
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.